Dr. Karen Reckamp is a Professor in Medicine, Director of the Division of Medical Oncology at Cedars-Sinai Medical Center in Los Angeles, California.
Podcasts
Vascular & IR # 595Dec 5, 2025Lung Cancer Staging & Systemic Therapies: Recent Advancements
How do leading oncologists interpret the abundance of molecular tests, genomic data, and biomarkers to create a lung cancer patient’s treatment plan? In this episode of the 2025 NSCLC Creator Weekend™ series, our tumor board discusses the complexities of lung cancer treatment, including new systemic therapies, lung cancer staging, and the role of molecular diagnostics and liquid biopsies.
- Vascular & IR # 591Nov 21, 2025
NSCLC Tumor Board Discussion: Considerations for Oligometastatic Disease
When cancer spreads to the brain, what is the best approach: immediate local treatment or systemic immunotherapy first? Part two of the 2025 NSCLC Creator Weekend™ series focuses on a complex case involving a 75-year-old woman with a history of breast malignancy, presenting with new dyspnea and a large mass in the left lower lobe.
Tumor Board # 36Nov 18, 2025Lung Cancer Staging & Systemic Therapies: Recent Advancements
How do leading oncologists interpret the abundance of molecular tests, genomic data, and biomarkers to create a lung cancer patient’s treatment plan? In this episode of the 2025 NSCLC Creator Weekend™ series, our tumor board discusses the complexities of lung cancer treatment, including new systemic therapies, lung cancer staging, and the role of molecular diagnostics and liquid biopsies.
- Vascular & IR # 589Nov 14, 2025
Lung Cancer Tumor Boards: Multidisciplinary Approaches & Best Practices
As lung cancer treatments become more complex, is a collaborative tumor board more essential than ever? We’re kicking off the 2025 NSCLC Creator Weekend™ series with an in-studio panel discussion on the multidisciplinary management of lung cancer. The panel includes experts from medical oncology, thoracic surgery, radiation oncology, and interventional pulmonology from major institutions in Los Angeles.
- Tumor Board # 35Nov 14, 2025
NSCLC Tumor Board Discussion: Considerations for Oligometastatic Disease
When cancer spreads to the brain, what is the best approach: immediate local treatment or systemic immunotherapy first? Part two of the 2025 NSCLC Creator Weekend™ series focuses on a complex case involving a 75-year-old woman with a history of breast malignancy, presenting with new dyspnea and a large mass in the left lower lobe.
- Tumor Board # 34Nov 11, 2025
Lung Cancer Tumor Boards: Multidisciplinary Approaches & Best Practices
As lung cancer treatments become more complex, is a collaborative tumor board more essential than ever? We’re kicking off the 2025 NSCLC Creator Weekend™ series with an in-studio panel discussion on the multidisciplinary management of lung cancer. The panel includes experts from medical oncology, thoracic surgery, radiation oncology, and interventional pulmonology from major institutions in Los Angeles.